Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies. (Q54347202)

28 May 2018

meta-analysis

0 references

title

Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies. (English)

1 reference

28 May 2018

1 reference

Yu Liu

1

1 reference

28 May 2018

Yun-Hong Ma

2

1 reference

28 May 2018

Zhen-Zhong Sun

3

1 reference

28 May 2018

Yong-Jun Rui

4

1 reference

28 May 2018

Qu-Dong Yin

5

1 reference

28 May 2018

Sheng Song

6

1 reference

28 May 2018

Xu-Ming Wei

7

1 reference

28 May 2018

Jun Liu

8

1 reference

28 May 2018

Xue-Guang Liu

9

1 reference

28 May 2018

Ke-Jia Hu

10

1 reference

28 May 2018

publication date

5 June 2014

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

35

1 reference

28 May 2018

issue

9

1 reference

28 May 2018

page(s)

8939-8943

1 reference

28 May 2018

Pancreatic metastasis from osteosarcoma and Ewing sarcoma: literature review

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Biomarkers in Osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

The etiology of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

New targets and approaches in osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Adjuvant trastuzumab in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

C-erbB-2 expression and prognostic significance in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Targeting the osteosarcoma cancer stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

A review of the association between osteosarcoma metastasis and protein translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Prognostic role of CD133 expression in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

Survival in high-grade osteosarcoma: improvement over 21 years at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2165-9

ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma

21 January 2018

1 reference

12 December 2020

Osteosarcoma: clinical practice and the expanding role of biology

1 reference

12 December 2020

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

12 December 2020

Cancer stem cells: an evolving concept

1 reference

12 December 2020

ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma

1 reference

12 December 2020

The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: A pilot study

1 reference

12 December 2020

Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma

1 reference

12 December 2020

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

1 reference

12 December 2020

CDH11 expression is associated with survival in patients with osteosarcoma

1 reference

12 December 2020

Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients

1 reference

12 December 2020

Expression of molecular markers in the tumor and survival prognosis in osteosarcoma

1 reference

12 December 2020

10.1007/S13277-014-2165-9

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018